Skip to Main Content
Somerset Prescribing Formulary
  • Home
  • [[ INDEX ]]
  • Admission and Discharge Processes
  • BNF Therapeutic
    • Chapters 1-5
      • Chapter 1 – Gastro-intestinal system
      • Chapter 2 – Cardiovascular system
      • Chapter 3 – Respiratory system
      • Chapter 4 – Nervous system
      • Chapter 5 – Infection
    • Chapters 6-10
      • Chapter 6 – Endocrine system
      • Chapter 7 – Genito-urinary system
      • Chapter 8 – Immune system and malignant disease
      • Chapter 9 – Blood and nutrition
      • Chapter 10 – Musculoskeletal system
    • Chapters 11-15
      • Chapter 11 – Eye
      • Chapter 12 – Ear, nose and oropharynx
      • Chapter 13 – Skin
      • Chapter 15 – Anaesthesia
    • Appendix 2
  • Publications
  • NHS Somerset website
  • Useful Links

Chapter 4 – Central Nervous System

4.1 - Hypnotics and anxiolytics
4.2 - Drugs used in psychoses and related disorders
4.2.3 - Antimanic drugs
4.3 - Antidepressants
4.5 - CNS stimulants and drugs for ADHD
4.5.1 - Drugs used in the treatment of obesity
4.7 - Analgesics
4.7.3 - Neuropathic pain
4.7.4 - Antimigraine drugs
4.8.1 - Epilepsy
4.8.2 - Drugs used in status epilepticus
4.10 - Drugs used in substance dependence
4.11 - Drugs for dementia

DVLA Guidance:

Neurological disorders: Assessing fitness to drive

Psychiatric disorders: Assessing fitness to drive

Drug or alcohol misuse or dependence: Assessing fitness to drive

We believe the information in this document is correct at the time of production.  Please notify the Medicines Management Team of any errors.
shelley.hodder@nhs.net Team Administrator
© 2022 Somerset CCG